Immunotheraphy in allergic diseases

Albert Roger, Maria Basagaña, Aina Teniente-Serra, Nathalie Depreux, Yanina Jurgens, Clara Padró, Sira Miquel, Carolina Elduque, Eva M. Martinez-Caceres

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

© 2018 Bentham Science Publishers. The prevalence of allergic diseases is increasing worldwide. It is estimated that more than 30% of the world population is now affected by one or more allergic conditions and a high proportion of this increase is in young people. The diagnosis of allergy is dependent on a history of symptoms on exposure to an allergen together with the detection of allergen-specific IgE. Accurate diagnosis of allergies opens up therapeutic options. Allergen specific immunotherapy is the only successful disease-modifying therapy for IgE-mediated allergic diseases. New therapeutic strategies have been developed or are currently under clinical trials. Besides new routes of administration, new types of allergens are being developed. The use of adjuvants may amplify the immune response towards tolerance to the antigens. In this review, we analyze different antigen-specific immunotherapies according to administration route, type of antigens and adjuvants, and we address the special case of food allergy.
Original languageEnglish
Pages (from-to)1174-1194
JournalCurrent Pharmaceutical Design
Volume24
Issue number11
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Adjuvants
  • Allergy
  • Antigens
  • IgE
  • Immunotherapy
  • Tolerance

Fingerprint Dive into the research topics of 'Immunotheraphy in allergic diseases'. Together they form a unique fingerprint.

  • Cite this

    Roger, A., Basagaña, M., Teniente-Serra, A., Depreux, N., Jurgens, Y., Padró, C., Miquel, S., Elduque, C., & Martinez-Caceres, E. M. (2018). Immunotheraphy in allergic diseases. Current Pharmaceutical Design, 24(11), 1174-1194. https://doi.org/10.2174/1381612824666180116094048